Magstim TMS is a treatment cleared by the US Food and Drug Administration (FDA) for patients suffering from depression who have not achieved satisfactory improvement from antidepressant medication. Transcranial Magnetic Stimulation (TMS) is a form of non-invasive brain stimulation, with over 30 years of application in neuroscientific and clinical research around the world.
TMS Therapy is a treatment that can be performed in a psychiatrist's office, under his or her supervision, using a medical device called the Magstim Horizon® system. Magstim TMS is:
- Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment
- Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.
The typical initial treatment course consists of at least 5 treatments per week over a 4-6 week period, for an average of 20-30 total treatments. Each treatment session lasts approximately 19-40 minutes, depending on what the doctor determines is the correct protocol.
TMS+YOU is an online community and national patient advocacy site for TMS Therapy. Those considering Transcranial Magnetic Stimulation can connect with patients who have had the treatment to answer questions, share insights, and get the latest information.